Effectiveness of EGFR‐TKI rechallenge immediately after PD‐1 blockade failure

BACKGROUND: There is currently insufficient information available on effective therapies that can be administered to patients with non‐small cell cancer (NSCLC) who develop resistance to epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKIs). However, sequential treatment via progra...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorac Cancer
Main Authors: Kaira, Kyoichi, Kobayashi, Kunihiko, Shiono, Ayako, Yamaguchi, Ou, Hashimoto, Kosuke, Mouri, Atsuto, Shinomiya, Shun, Miura, Yu, Imai, Hisao, Kagamu, Hiroshi
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons Australia, Ltd 2021
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7952801/
https://ncbi.nlm.nih.gov/pubmed/33522139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13864
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados